140 related articles for article (PubMed ID: 8824249)
1. Plasminogen activator inhibitor type 2 gene induction by tumor necrosis factor and phorbol ester involves transcriptional and post-transcriptional events. Identification of a functional nonameric AU-rich motif in the 3'-untranslated region.
Maurer F; Medcalf RL
J Biol Chem; 1996 Oct; 271(42):26074-80. PubMed ID: 8824249
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs.
Tierney MJ; Medcalf RL
J Biol Chem; 2001 Apr; 276(17):13675-84. PubMed ID: 11278713
[TBL] [Abstract][Full Text] [Related]
3. An AU-rich sequence in the 3'-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR.
Maurer F; Tierney M; Medcalf RL
Nucleic Acids Res; 1999 Apr; 27(7):1664-73. PubMed ID: 10075998
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA.
Dear AE; Costa M; Medcalf RL
FEBS Lett; 1997 Feb; 402(2-3):265-72. PubMed ID: 9037208
[TBL] [Abstract][Full Text] [Related]
5. Control of plasminogen-activator inhibitor type 2 gene expression in the differentiation of monocytic cells.
Antalis TM; Dickinson JL
Eur J Biochem; 1992 Apr; 205(1):203-9. PubMed ID: 1555580
[TBL] [Abstract][Full Text] [Related]
6. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor.
Scarpati EM; Sadler JE
J Biol Chem; 1989 Dec; 264(34):20705-13. PubMed ID: 2555368
[TBL] [Abstract][Full Text] [Related]
7. Different regulation of plasminogen activator inhibitor 2 gene expression by phorbol ester and cAMP in human myeloid leukemia cell line PL-21.
Niiya K; Taniguchi T; Shinbo M; Ishikawa T; Tazawa S; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1994 Jul; 72(1):92-7. PubMed ID: 7974383
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional antagonism of phorbol ester-mediated induction of plasminogen activator inhibitor types 1 and 2 by cyclic adenosine 3',5'-monophosphate.
Bergonzelli GE; Kruithof EK; Medcalf RL
Endocrinology; 1992 Sep; 131(3):1467-72. PubMed ID: 1354603
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms governing tumor-necrosis-factor-mediated regulation of plasminogen-activator inhibitor type-2 gene expression.
Dear AE; Shen Y; Rüegg M; Medcalf RL
Eur J Biochem; 1996 Oct; 241(1):93-100. PubMed ID: 8898893
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor type-2 (PAI-2) gene transcription requires a novel NF-kappaB-like transcriptional regulatory motif.
Mahony D; Kalionis B; Antalis TM
Eur J Biochem; 1999 Aug; 263(3):765-72. PubMed ID: 10469140
[TBL] [Abstract][Full Text] [Related]
11. Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells.
Bosma PJ; Kooistra T
J Biol Chem; 1991 Sep; 266(27):17845-9. PubMed ID: 1655729
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of a dominant negative CREB protein in HT-1080 cells selectively disrupts plasminogen activator inhibitor type 2 but not tissue-type plasminogen activator gene expression.
Costa M; Shen Y; Medcalf RL
FEBS Lett; 2000 Sep; 482(1-2):75-80. PubMed ID: 11018526
[TBL] [Abstract][Full Text] [Related]
13. On the role of c-Jun in the induction of PAI-1 gene expression by phorbol ester, serum, and IL-1alpha in HepG2 cells.
Arts J; Grimbergen J; Toet K; Kooistra T
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):39-46. PubMed ID: 9888864
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
Schuster WA; Medcalf RL; Kruithof EK
Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
[TBL] [Abstract][Full Text] [Related]
15. Inherent instability of plasminogen activator inhibitor type 2 mRNA is regulated by tristetraprolin.
Yu H; Stasinopoulos S; Leedman P; Medcalf RL
J Biol Chem; 2003 Apr; 278(16):13912-8. PubMed ID: 12578825
[TBL] [Abstract][Full Text] [Related]
16. Cyclic nucleotide regulation of type-1 plasminogen activator-inhibitor mRNA stability in rat hepatoma cells. Identification of cis-acting sequences.
Heaton JH; Tillmann-Bogush M; Leff NS; Gelehrter TD
J Biol Chem; 1998 Jun; 273(23):14261-8. PubMed ID: 9603932
[TBL] [Abstract][Full Text] [Related]
17. Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial cells.
Shetty S; Velusamy T; Shetty RS; Marudamuthu AS; Shetty SK; Florova G; Tucker T; Koenig K; Shetty P; Bhandary YP; Idell S
Am J Respir Cell Mol Biol; 2010 Sep; 43(3):358-67. PubMed ID: 19855086
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the plasminogen activator inhibitor type-2 gene in monocytes: localization of an upstream transcriptional silencer.
Antalis TM; Costelloe E; Muddiman J; Ogbourne S; Donnan K
Blood; 1996 Nov; 88(10):3686-97. PubMed ID: 8916932
[TBL] [Abstract][Full Text] [Related]
19. The plasminogen activator inhibitor 2 transcript is destabilized via a multi-component 3' UTR localized adenylate and uridylate-rich instability element in an analogous manner to cytokines and oncogenes.
Stasinopoulos S; Mariasegaram M; Gafforini C; Nagamine Y; Medcalf RL
FEBS J; 2010 Mar; 277(5):1331-44. PubMed ID: 20392207
[TBL] [Abstract][Full Text] [Related]
20. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.
Peraldi MN; Rondeau E; Medcalf RL; Hagège J; Lacave R; Delarue F; Schleuning WD; Sraer JD
Biochim Biophys Acta; 1992 Apr; 1134(3):189-96. PubMed ID: 1558843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
